Version 1
: Received: 22 January 2019 / Approved: 24 January 2019 / Online: 24 January 2019 (08:46:50 CET)
How to cite:
Ona, G.; Bouso, J.C. Can Psychedelics be the Treatment for the Crisis in Psychopharmacology?. Preprints2019, 2019010249. https://doi.org/10.20944/preprints201901.0249.v1
Ona, G.; Bouso, J.C. Can Psychedelics be the Treatment for the Crisis in Psychopharmacology?. Preprints 2019, 2019010249. https://doi.org/10.20944/preprints201901.0249.v1
Ona, G.; Bouso, J.C. Can Psychedelics be the Treatment for the Crisis in Psychopharmacology?. Preprints2019, 2019010249. https://doi.org/10.20944/preprints201901.0249.v1
APA Style
Ona, G., & Bouso, J.C. (2019). Can Psychedelics be the Treatment for the Crisis in Psychopharmacology?. Preprints. https://doi.org/10.20944/preprints201901.0249.v1
Chicago/Turabian Style
Ona, G. and José Carlos Bouso. 2019 "Can Psychedelics be the Treatment for the Crisis in Psychopharmacology?" Preprints. https://doi.org/10.20944/preprints201901.0249.v1
Abstract
The current crisis in psychopharmacology has a long history and needs to be addressed with innovative and effective strategies. Here we discuss some of the roots of this crisis and suggest that the therapeutic use of psychedelic drugs represents a promising and integrative treatment with enduring effects for mental health problems.
Medicine and Pharmacology, Psychiatry and Mental Health
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
